NMR solution structure of PawS Derived Peptide 20 (PDP-20)
ID | Type | Value order | Atom ID 1 | Atom ID 2 |
---|---|---|---|---|
1 | disulfide | sing | 1:CYS3:SG | 1:CYS13:SG |
2 | covalent | sing | 1:GLY1:N | 1:ASP16:C |
Polymer type: polypeptide(L)
Total | 1H | 13C | 15N | |
---|---|---|---|---|
All | 80.3 % (139 of 173) | 97.8 % (87 of 89) | 55.7 % (39 of 70) | 92.9 % (13 of 14) |
Backbone | 80.4 % (74 of 92) | 100.0 % (32 of 32) | 63.0 % (29 of 46) | 92.9 % (13 of 14) |
Sidechain | 82.1 % (78 of 95) | 96.5 % (55 of 57) | 60.5 % (23 of 38) | |
Aromatic | 40.0 % (8 of 20) | 80.0 % (8 of 10) | 0.0 % (0 of 10) | |
Methyl | 75.0 % (9 of 12) | 100.0 % (6 of 6) | 50.0 % (3 of 6) |
1. PawS Derived Peptide 20 (PDP-20)
GICFKDPFGS TLCAPDSolvent system 90% H2O/10% D2O, Pressure 1 atm, Temperature 283 K, pH 4
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
1 | PawS Derived Peptide 20 (PDP-20) | natural abundance | 1.8 mg/mL | |
2 | H2O | natural abundance | 90 % | |
3 | D2O | natural abundance | 10 % |
Solvent system 100% D2O, Pressure 1 atm, Temperature 283 K, pH 4
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
4 | PawS Derived Peptide 20 (PDP-20) | natural abundance | 1.8 mg/mL | |
5 | D2O | natural abundance | 100 % |